These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11501338)

  • 1. Is hormone replacement therapy protective for venous ulcer of the lower limbs?
    Bérard A; Kahn SR; Abenhaim L
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):245-51. PubMed ID: 11501338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for the first-time development of venous ulcers of the lower limbs: the influence of heredity and physical activity.
    Bérard A; Abenhaim L; Platt R; Kahn SR; Steinmetz O
    Angiology; 2002; 53(6):647-57. PubMed ID: 12463617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.
    Ramnath N; Menezes RJ; Loewen G; Dua P; Eid F; Alkhaddo J; Paganelli G; Natarajan N; Reid ME
    Oncology; 2007; 73(5-6):305-10. PubMed ID: 18493157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for chronic ulceration in patients with varicose veins: a case control study.
    Robertson L; Lee AJ; Gallagher K; Carmichael SJ; Evans CJ; McKinstry BH; Fraser SC; Allan PL; Weller D; Ruckley CV; Fowkes FG
    J Vasc Surg; 2009 Jun; 49(6):1490-8. PubMed ID: 19497512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.
    Douketis JD; Julian JA; Crowther MA; Kearon C; Bates SM; Barone M; Piovella F; Middeldorp S; Prandoni P; Johnston M; Costantini L; Ginsberg JS
    Clin Appl Thromb Hemost; 2011; 17(6):E106-13. PubMed ID: 21159708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy with estradiol and risk of venous thromboembolism--a population-based case-control study.
    Høibraaten E; Abdelnoor M; Sandset PM
    Thromb Haemost; 1999 Oct; 82(4):1218-21. PubMed ID: 10544901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of body mass index and age on deep vein thrombosis after total hip and knee arthroplasty].
    Guan Z; Chen Y; Song Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Jun; 20(6):611-5. PubMed ID: 16827383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
    Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
    Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study.
    Potter JD; Bostick RM; Grandits GA; Fosdick L; Elmer P; Wood J; Grambsch P; Louis TA
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):779-84. PubMed ID: 8896888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
    Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
    J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study on the effect of hormone replacement therapy on ischaemic heart disease.
    Hippisley-Cox J; Pringle M; Crown N; Coupland C
    Br J Gen Pract; 2003 Mar; 53(488):191-6. PubMed ID: 14694694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the risk factors of deep venous thrombosis in acute hospitalized stroke patients].
    Sun KK; Wang C; Pang BS; Yang YH; He W; Chen TF; Zhao QH; Zhang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1019-23. PubMed ID: 15769354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT; Hunt N; Strachan RK; Nicolaides AN
    Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with recurrence of venous leg ulcers: a survey and retrospective chart review.
    Finlayson K; Edwards H; Courtney M
    Int J Nurs Stud; 2009 Aug; 46(8):1071-8. PubMed ID: 19185862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
    Bradbury BD; Lash TL; Kaye JA; Jick SS
    Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous thromboembolism in users of hormone replacement therapy.
    Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
    Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.